Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Post-market Surveillance Study of the BD® WavelinQ™ EndoAVF System

NCT: NCT04634916 · RECRUITING

NCT IDNCT04634916
StatusRECRUITING
Start Date2021-03-26
SponsorC. R. Bard (INDUSTRY)
First posted
Last updated

Brief Summary

A prospective, single-arm, multi-center post-market surveillance study of the BD® WavelinQ™ EndoAVF System for the Creation of Arteriovenous (AV) Fistula in Patients Requiring Dialysis.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑